LONDON (Reuters) - Women with mutations in a gene called PALB2 have a one in three chance of developing breast cancer by age 70, according to research that suggests PALB2 is almost as important a risk ...
Hereditary breast cancer results from inherited mutations, primarily in BRCA1 and BRCA2, increasing lifetime cancer risk. Additional genes like TP53, PTEN, PALB2, CHEK2, and ATM also contribute to ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...
The SHARON trial combines chemotherapy, vitamins, and stem cells to treat advanced pancreatic cancer with BRCA or PALB2 mutations, showing promising early results. This precision medicine approach ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.
Sisters Mary Pat and Susan O'Hern have battled breast cancer multiple times over two decades. A shared PALB2 gene mutation increased their risk for the disease, impacting other family members as well.
When most people think about cancer, they think of bad luck, lifestyle choices, or something that “just happens.” Very few ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback